Anthony T. Tu

Dr. Anthony T. Tu


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2020 in Toxins
Verified
Journal Article
Open access
PDF file
Kun-Che ChangKun-Che Chang
Kun-Che Chang
YHyukai Huang
yukai Huang
YCYen-Wen Chen
Yen-Wen Chen
MCMin-Hui Chen
Min-Hui Chen
ATAnthony T. Tu
Anthony T. Tu
YCYen-Chia Chen
Yen-Chia Chen
Little is known about the detailed clinical description, pathophysiology, and efficacy of treatments for ocular envenoming (venom ophthalmia) caused by venom of the spitting elapid and other snakes, as well as ocular complications caused by snake venom injection. In this paper, we review clinical information of case reports regarding venom ophthalmia and snake venom injection with associated ocular injuries in Asia, Africa, and the United States. We also review the literature of snake venom such as their compositions, properties, and toxic effects. Based on the available clinical information and animal studies, we further discuss possible mechanisms of venom ophthalmia derived from two different routes (Duvernoy’s gland in the mouth and nuchal gland in the dorsal neck) and the pathophysiology of snake venom injection induced ocular complications, including corneal edema, corneal erosion, cataract, ocular inflammation, retinal hemorrhage, acute angle closure glaucoma, as well as ptosis, diplopia, and photophobia. Finally, we discuss the appropriate first aid and novel strategies for treating venom ophthalmia and snake envenoming.

27 June 2022 in Toxins
Verified
Journal Article
Open access
PDF file
YHyukai Huang
yukai Huang
YCYen-Chia Chen
Yen-Chia Chen
CLChia-Chun Liu
Chia-Chun Liu
HCHui-Chun Cheng
Hui-Chun Cheng
ATAnthony T. Tu
Anthony T. Tu
Kun-Che ChangKun-Che Chang
Kun-Che Chang
There are an estimated 5.4 million snakebite cases every year. People with snakebite envenoming suffer from severe complications, or even death. Although some review articles cover several topics of snakebite envenoming, a review of the cases regarding cerebral complications, especially rare syndromes, is lacking. Here, we overview 35 cases of snakebite by front-fanged snakes, including Bothrops, Daboia, Cerastes, Deinagkistrodon, Trimeresurus, and Crotalus in the Viperidae family; Bungarus and Naja in the Elapidae family, and Homoroselaps (rare cases) in the Lamprophiidae family. We also review three rare cases of snakebite by rear-fanged snakes, including Oxybelis and Leptodeira in the Colubridae family. In the cases of viper bites, most patients (17/24) were diagnosed with ischemic stroke and intracranial hemorrhage, leading to six deaths. We then discuss the potential underlying molecular mechanisms that cause these complications. In cases of elapid bites, neural, cardiac, and ophthalmic disorders are the main complications. Due to the small amount of venom injection and the inability to deep bite, all the rear-fanged snakebites did not develop any severe complications. To date, antivenom (AV) is the most effective therapy for snakebite envenoming. In the six cases of viper and elapid bites that did not receive AV, three cases (two by viper and one by elapid) resulted in death. This indicates that AV treatment is the key to survival after a venomous snakebite. Lastly, we also discuss several studies of therapeutic agents against snakebite-envenoming-induced complications, which could be potential adjuvants along with AV treatment. This article organizes the diagnosis of hemotoxic and neurotoxic envenoming, which may help ER doctors determine the treatment for unidentified snakebite.

1 January 2020 in Global Security: Health, Science and Policy
Verified
Journal Article
Open access
ATAnthony T. Tu
Anthony T. Tu
VX is a strong nerve-gas agent. In this paper, murder or injury of human made by VX is reported. First use of VX against human was made by Aum Shimrikyo in 1994 and 1995. More recently, VX was used in the assassination of Mr. Kim Jong-Nam in Kuala Lumpur, Malaysia, on 13 February 2017. In this review article, the use of VX against human is discussed together and described in detail.


8 December 2009 in Toxins
Verified
Journal Article
Open access
PDF file
MNMasaya Nagamizu
Masaya Nagamizu
YKYumiko Komori
Yumiko Komori
KUKei-Ichi Uchiya
Kei-Ichi Uchiya
TNToshiaki Nikai
Toshiaki Nikai
ATAnthony T. Tu
Anthony T. Tu
Sea snakes (family: Hydrophiidae) are serpents found in the coastal areas of the Indian and Pacific Oceans. There are two subfamilies in Hydrophiidae: Hydrophiinae and Laticaudinae. A toxin, aagardi toxin, was isolated from the venom of the Hydrophiinae snake, Hydrophis torquatus aagardi and its chemical properties such as molecular weight, isoelectric point, importance of disulfide bonds, lack of enzymatic activity and amino acid sequence were determined. The amino acid sequence indicated a close relationship to the primary structure of other Hydrophiinae toxins and a significant difference from Laticaudinae toxins, confirming that primary toxin structure is closely related to sea snake phylogenecity.

3 December 2009 in Toxins
Verified
Journal Article
Open access
PDF file
YKYumiko Komori
Yumiko Komori
MNMasaya Nagamizu
Masaya Nagamizu
KUKei-Ichi Uchiya
Kei-Ichi Uchiya
TNToshiaki Nikai
Toshiaki Nikai
ATAnthony T. Tu
Anthony T. Tu
Both sea snakes and cobras have venoms containing postsynaptic neurotoxins. Comparison of the primary structures indicates many similarities, especially the positions of the four disulfide bonds. However, detailed examination reveals differences in several amino acid residues. Amino acid sequences of sea snake neurotoxins were determined, and then compared to cobra neurotoxins by computer modeling. This allowed for easy comparison of the similarities and differences between the two types of postsynaptic neurotoxins. Comparison of computer models for the toxins of sea snakes and cobra will reveal the three dimensional difference of the toxins much clearer than the amino acid sequence alone.